X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-30 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $3.20 | -18,589 | 3,120,569 | -1% | -$59,429 | ||||||
2024-09-30 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $3.20 | -18,589 | 3,220,569 | -1% | -$59,414 | ||||||
2024-09-30 | AMLX | Bedrosian Camille L | Chief Medical Officer | S - Sale | $3.20 | -11,442 | 143,801 | -7% | -$36,559 | ||||||
2024-09-30 | AMLX | Mazzariello Gina | GC | S - Sale | $3.20 | -8,709 | 142,768 | -6% | -$27,840 | ||||||
2024-09-12 | AMLX | Frates James M | CFO | P - Purchase | $2.53 | +40,000 | 259,995 | +18% | +$101,368 | ||||||
2024-09-05 | AMLX | Firestone Karen | Dir | P - Purchase | $2.13 | +50,000 | 55,000 | >999% | +$106,590 | ||||||
2024-09-03 | AMLX | Milne George M Jr | Dir | P - Purchase | $2.20 | +100,000 | 858,571 | +13% | +$219,800 | ||||||
M | 2024-05-14 | AMLX | Quimi Daphne | Dir | P - Purchase | $1.89 | +5,000 | 5,000 | New | +$9,436 | |||||
2024-05-15 | AMLX | Mazzariello Gina | GC | S - Sale | $1.88 | -10,455 | 151,477 | -6% | -$19,654 | ||||||
2024-03-05 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $18.73 | -4,135 | 3,023,002 | 0% | -$77,440 | ||||||
2024-03-05 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $18.73 | -4,135 | 2,959,308 | 0% | -$77,440 | ||||||
2024-03-05 | AMLX | Frates James M | CFO | S - Sale | $18.73 | -1,792 | 161,315 | -1% | -$33,560 | ||||||
2024-03-05 | AMLX | Mazzariello Gina | GC | S - Sale | $18.73 | -1,540 | 81,372 | -2% | -$28,841 | ||||||
2024-02-23 | AMLX | Mazzariello Gina | GC | S - Sale | $18.76 | -2,838 | 46,245 | -6% | -$53,231 | ||||||
2024-01-09 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $16.33 | -5,841 | 2,836,776 | 0% | -$95,372 | ||||||
2024-01-09 | AMLX | Frates James M | CFO | S - Sale | $16.33 | -2,716 | 123,107 | -2% | -$44,347 | ||||||
2024-01-09 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $16.33 | -5,841 | 2,900,470 | 0% | -$95,372 | ||||||
2024-01-09 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale | $16.33 | -2,812 | 205,605 | -1% | -$45,915 | ||||||
2023-12-15 | AMLX | Firestone Karen | Dir | P - Purchase | $14.97 | +4,000 | 5,000 | +400% | +$59,880 | ||||||
2023-08-15 | AMLX | Mazzariello Gina | GC | S - Sale | $20.88 | -6,164 | 49,083 | -11% | -$128,686 | ||||||
D | 2023-05-16 | AMLX | Frates James M | CFO | S - Sale+OE | $26.94 | -32,500 | 75,158 | -30% | -$875,451 | |||||
D | 2023-05-15 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $29.03 | -11,965 | 208,417 | -5% | -$347,358 | |||||
D | 2023-04-17 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $30.54 | -49,579 | 208,417 | -19% | -$1,513,942 | |||||
2023-03-29 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $30.45 | -29,048 | 6,997,302 | 0% | -$884,512 | ||||||
M | 2023-03-27 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $30.42 | -160,964 | 7,026,350 | -2% | -$4,896,561 | |||||
AD | 2023-03-16 | AMLX | Frates James M | CFO | S - Sale+OE | $31.89 | -32,500 | 55,676 | -37% | -$1,036,459 | |||||
AD | 2023-03-16 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $31.87 | -54,627 | 208,417 | -21% | -$1,741,200 | |||||
2023-03-21 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $31.91 | -63,448 | 7,187,314 | -1% | -$2,024,494 | ||||||
D | 2023-03-16 | AMLX | Klee Justin B. | Co-CEO | S - Sale+OE | $31.86 | -100,000 | 2,842,617 | -3% | -$3,186,236 | |||||
2023-03-16 | AMLX | Milne George M Jr | Dir | S - Sale | $31.89 | -35,000 | 862,021 | -4% | -$1,116,072 | ||||||
D | 2023-03-16 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $31.87 | -54,627 | 158,839 | -26% | -$1,741,200 | |||||
D | 2023-03-16 | AMLX | Firestone Karen | Dir | P - Purchase | $31.99 | +1,000 | 1,000 | New | +$31,990 | |||||
D | 2023-03-16 | AMLX | Cohen Joshua B | Co-CEO | S - Sale+OE | $31.86 | -100,000 | 2,842,617 | -3% | -$3,186,336 | |||||
D | 2023-03-16 | AMLX | Frates James M | CFO | S - Sale+OE | $31.89 | -32,500 | 23,176 | -58% | -$1,036,459 | |||||
2023-03-16 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $32.55 | -9,122 | 7,250,762 | 0% | -$296,921 | ||||||
M | 2023-03-14 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $33.68 | -220,714 | 7,259,884 | -3% | -$7,433,459 | |||||
2023-03-02 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $33.75 | -50,000 | 7,480,598 | -1% | -$1,687,500 | ||||||
2023-02-24 | AMLX | Mazzariello Gina | GC | S - Sale | $34.49 | -3,586 | 37,414 | -9% | -$123,672 | ||||||
2023-02-22 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $34.73 | -50,000 | 7,530,598 | -1% | -$1,736,352 | ||||||
M | 2023-02-22 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $35.78 | -100,000 | 7,580,598 | -1% | -$3,578,103 | |||||
2023-01-06 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale | $36.30 | -2,034 | 204,299 | -1% | -$73,831 | ||||||
2023-01-06 | AMLX | Cohen Joshua B | Co-CEO | S - Sale | $36.30 | -5,968 | 2,892,617 | 0% | -$216,629 | ||||||
2023-01-06 | AMLX | Frates James M | CFO | S - Sale | $36.30 | -2,658 | 34,009 | -7% | -$96,481 | ||||||
2023-01-06 | AMLX | Olinger Margaret | Chief Commercial Officer | S - Sale | $36.30 | -2,403 | 214,355 | -1% | -$87,225 | ||||||
2023-01-06 | AMLX | Klee Justin B. | Co-CEO | S - Sale | $36.30 | -5,968 | 2,892,617 | 0% | -$216,629 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |